SGO1 and neoplasm: As shown in Table 1 and Figures 3A–G, SGO1 expression was significantly associated with pathological stage (P = 0.001), T stage (P < 0.001), N stage (P = 0.005), M stage (P = 0.009), gender (P = 0.001), residual tumor gender (P = 0.019), and age (P = 0.006).